US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Takeda Pharmaceutical Co Ltd

15.32

+0.29001.93%

Post-market: 15.320.00000.00%16:58 EDT

Volume:1.39M

Turnover:21.25M

Market Cap:48.35B

PE:37.01

High:15.39

Open:15.30

Low:15.29

Close:15.03

Loading ...

Overview Company News Filings

Takeda Pharmaceutical Expected to Post Lower Third-Quarter Net Profit -- Earnings Preview

Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights

Stocks to Watch: Graco, Brown & Brown, Neurocrine Biosciences

Neurocrine Amends Collaboration with Takeda on Osavampator

MT Newswires Live

Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment

Neurocrine announces amendment to collaboration with Takeda

Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal

MT Newswires Live

Takeda Recognized as a Top Employer in Canada for Third Consecutive Year

Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept

Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla

MT Newswires Live

Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)

ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?

Verizon Frontline showcases advanced communications solutions at EDGE25

Sector Update: Health Care Stocks Mixed Pre-Bell Friday

MT Newswires Live

Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency

Takeda announces Japan MHLW approval for new Hyqvia use

Takeda Pharmaceutical's Hyqvia Approved in Japan for Patients With Immune Disorders

MT Newswires Live

TD Cowen Reaffirms Their Buy Rating on Takeda Pharmaceutical Company (TAK)

Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative

Takeda Announces Subsidiary Liquidation and Merger Completion

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/TAK/news?page=3"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"TAK","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","market":"US","secType":"STK","nameCN":"Takeda Pharmaceutical Co Ltd","latestPrice":15.32,"timestamp":1746216000000,"preClose":15.03,"halted":0,"volume":1387023,"hourTrading":{"tag":"盘后","latestPrice":15.32,"preClose":15.32,"latestTime":"16:58 EDT","volume":3634,"amount":55673.61,"timestamp":1746219520966},"delay":0,"floatShares":3021115373,"shares":3156322898,"eps":0.413946,"marketStatus":"Not Yet Opened","change":0.29,"latestTime":"05-02 16:00:00 EDT","open":15.3,"high":15.39,"low":15.285,"amount":21248436.432465,"amplitude":0.006986,"askPrice":0,"askSize":0,"bidPrice":0,"bidSize":0,"shortable":3,"etf":0,"ttmEps":0.413946,"tradingStatus":0,"nextMarketStatus":{"tag":"Pre-Mkt","tradingStatus":1,"beginTime":1746432000000},"marketStatusCode":0,"adr":0,"adrRate":0.5,"listingDate":1545627600000,"exchange":"NYSE","adjPreClose":15.03,"dividendRate":0.020235,"preHourTrading":{"tag":"盘前","latestPrice":14.87,"preClose":15.03,"latestTime":"09:22 EDT","volume":82,"amount":1232.360042,"timestamp":1746192133593},"postHourTrading":{"tag":"盘后","latestPrice":15.32,"preClose":15.32,"latestTime":"16:58 EDT","volume":3634,"amount":55673.61,"timestamp":1746219520966},"volumeRatio":0.8339106079386022,"impliedVol":0.2693,"impliedVolPercentile":0.364},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"TAK\",,,,,undefined,":{"symbol":"TAK","floatShares":3021115373,"roa":"2.51%","roe":"2.94%","lyrEps":0.304413,"volumeRatio":0.8339106079386022,"shares":3156322898,"dividePrice":0.31,"high":15.39,"amplitude":0.006986,"preClose":15.03,"low":15.285,"week52Low":12.575,"pbRate":"0.94","psRate":"1.52","week52High":15.39,"institutionHeld":0.1164,"latestPrice":15.32,"eps":0.413946,"divideRate":0.020235,"volume":1387023,"delay":0,"ttmEps":0.413946,"open":15.3,"prevYearClose":13.24,"prevWeekClose":15.03,"prevMonthClose":15.29,"prevQuarterClose":14.87,"fiveDayClose":15.03,"twentyDayClose":15.19,"sixtyDayClose":13.37,"earningDate":1746633600000,"earningTime":"盘前"},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"TAK\",pageSize:20,pageCount:3,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2507683699","title":"Takeda Pharmaceutical Expected to Post Lower Third-Quarter Net Profit -- Earnings Preview","url":"https://stock-news.laohu8.com/highlight/detail?id=2507683699","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2507683699?lang=en_us&edition=fundamental","pubTime":"2025-01-29 17:10","pubTimestamp":1738141800,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical is scheduled to report third-quarter results on Thursday. Here's what you need to know:. NET PROFIT FORECAST: Takeda is expected to post a 59% drop in net profit to 43.58 billion yen, equivalent to $280.2 million, for the three months ended Dec. 31, according to a poll of analysts by data provider LSEG. That would compare with Y105.7 billion net profit in the year-earlier period.REVENUE FORECAST: Third-quarter revenue is estimated to have grown 2.4% from a year earlier to Y1.138 trillion, according to the LSEG poll.The stock has declined 0.7% so far this year to close at Y4,153 on Wednesday, following a 3.1% gain in 2024.--For the fiscal year ending March, Takeda has projected that revenue will increase 5.1% to Y4.480 trillion and net profit will drop 53% to Y68.00 billion. Investors will be closely watching for any changes to the annual guidance.--Second-quarter sales of ulcerative colitis drug Entyvio climbed 20% to Y238.9 billion and sales of plasma-derived pro","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["TAK","POST"],"gpt_icon":0},{"id":"2506515510","title":"Neurocrine Obtains Exclusive Rights For Depression Drug, Takeda Reacquires Japan Rights","url":"https://stock-news.laohu8.com/highlight/detail?id=2506515510","media":"Benzinga","labels":["corporation","merge"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506515510?lang=en_us&edition=fundamental","pubTime":"2025-01-28 23:24","pubTimestamp":1738077864,"startTime":"0","endTime":"0","summary":"On Monday, Neurocrine Biosciences, Inc. amended its agreement with Takeda Pharmaceutical Co Ltd  to develop and commercialize osavampator .Under the amended agreement, Neurocrine will obtain exclusive rights for all indications to develop and commercialize osavampator for patients with inadequate response to treatment of major depressive disorder  in all territories worldwide exceptJapan, where Takeda will reacquire exclusive rights.Also Read: Neurocrine’s Drug Gains FDA Nod As First Targeted Treatment For Certain Type Of Inherited Disorder, Analyst Highlights Blockbuster Potential. “With the recent successful completion of our End-of-Phase 2 meeting with FDA for osavampator, we look forward to beginning the Phase 3 program in the first half of this year,” said Kyle Gano, Chief Executive Officer at Neurocrine Biosciences.In 2020,Neurocrine Biosciencesand Takeda entered into a strategic collaboration to develop and commercialize compounds in depression and schizophrenia, including an ex","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/neurocrine-obtains-exclusive-rights-depression-152424836.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation,merge","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU0109394709.USD","LU0823416689.USD","LU0889565916.HKD","LU2065170008.USD","LU2065171402.SGD","LU2065171311.SGD","LU2065169927.USD","LU2324357040.USD","BK4139","NBIX","BK4007","LU0320765992.SGD","TAK"],"gpt_icon":0},{"id":"2506534677","title":"Stocks to Watch: Graco, Brown & Brown, Neurocrine Biosciences","url":"https://stock-news.laohu8.com/highlight/detail?id=2506534677","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506534677?lang=en_us&edition=fundamental","pubTime":"2025-01-28 07:48","pubTimestamp":1738021680,"startTime":"0","endTime":"0","summary":"Graco posted lower sales in the fourth quarter as it continued to experience slower demand across many end markets. The manufacturer of fluid-handling systems reported adjusted earnings of 64 cents a share on revenue of $548.7 million, missing analyst expectations for adjusted earnings of 77 cents a share on revenue of $556.9 million. For 2025, the company expects low single-digit sales growth on an organic basis. Shares fall 5%, to $81.69, in after-hours trading.Brown & Brown's fourth-quarter revenue beat analyst expectations as commissions and fees rose. The insurance company said profit fell to $210 million from $269 million a year earlier, though adjusted per-share earnings of 86 cents and revenue of $1.18 billion beat the 77 cents a share and $1.12 billion that analysts polled by FactSet were expecting. Quarterly commissions and fees increased 15% in the quarter for annual growth of 12%. Shares rise 2.9%, to $111, in postmarket trading.","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK4588","LU2065171311.SGD","BK4585","LU0889565916.HKD","BK4173","LU0823416689.USD","LU2065170008.USD","LU2065169927.USD","BK4139","LU2065171402.SGD","LU0109394709.USD","BK4161","NBIX","GGG","LU2108987350.USD","BRO","LU2324357040.USD","BK4007","BK4597","IE00BKPKM429.USD","TAK","LU0320765992.SGD"],"gpt_icon":0},{"id":"2506548535","title":"Neurocrine Amends Collaboration with Takeda on Osavampator","url":"https://stock-news.laohu8.com/highlight/detail?id=2506548535","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506548535?lang=en_us&edition=fundamental","pubTime":"2025-01-28 06:28","pubTimestamp":1738016901,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) said it has obtained exclusive rights for all indications to develop and commercialize osavampator for patients with inadequate response to treatment of major depressive ","market":"nz","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["NBIX","BK4139","LU2065169927.USD","BK4007","LU0320765992.SGD","LU0889565916.HKD","LU2065170008.USD","LU2065171311.SGD","TAK","LU2065171402.SGD","LU0109394709.USD","LU2324357040.USD","LU0823416689.USD"],"gpt_icon":0},{"id":"2506535507","title":"Neurocrine Amends Agreement With Takeda for Major Depressive Disorder Treatment","url":"https://stock-news.laohu8.com/highlight/detail?id=2506535507","media":"Dow Jones","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506535507?lang=en_us&edition=fundamental","pubTime":"2025-01-28 06:21","pubTimestamp":1738016460,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences amended its agreement with Takeda Pharmaceutical regarding the development and commercialization of osavampator, a treatment for major depressive disorder.The San Diego biopharmaceutical company said Monday it will obtain exclusive rights for the drug in all territories worldwide except Japan, where Takeda will reacquire exclusive rights. Under the updated agreement, each company is responsible for development costs in their respective regions, and both companies are eligible to receive royalty payments.Chief Executive Kyle Gano said the new terms will streamline the collaboration structure, hopefully bringing the treatment to market faster.Neurocrine and Takeda, which is headquartered in Osaka, Japan, entered an agreement to develop and commercialize compounds for treatment of depression and schizophrenia in 2020.Osavampator is a potential treatment for major depressive disorder for patients who haven't benefited from treatment with at least one antidepressant i","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU0320765992.SGD","LU2065171311.SGD","LU0823416689.USD","NBIX","LU2065171402.SGD","LU2065170008.USD","BK4007","LU2065169927.USD","LU0109394709.USD","TAK","LU0889565916.HKD","LU2324357040.USD","BK4139"],"gpt_icon":0},{"id":"2506858703","title":"Neurocrine announces amendment to collaboration with Takeda","url":"https://stock-news.laohu8.com/highlight/detail?id=2506858703","media":"TIPRANKS","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2506858703?lang=en_us&edition=fundamental","pubTime":"2025-01-28 05:10","pubTimestamp":1738012234,"startTime":"0","endTime":"0","summary":"Neurocrine Biosciences (NBIX) announced it has amended its agreement with Takeda (TAK) to develop and commercialize osavampator. Under the amended ...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/neurocrine-announces-amendment-to-collaboration-with-takeda?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/neurocrine-announces-amendment-to-collaboration-with-takeda?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","LU2065170008.USD","LU2324357040.USD","BK4139","NBIX","LU2065169927.USD","LU2065171402.SGD","LU0889565916.HKD","LU0109394709.USD","BK4007","LU0823416689.USD","LU0320765992.SGD","LU2065171311.SGD"],"gpt_icon":0},{"id":"2505626276","title":"Keros to Receive $200 Million From Takeda In Connection to Elritercept License Deal","url":"https://stock-news.laohu8.com/highlight/detail?id=2505626276","media":"MT Newswires Live","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505626276?lang=en_us&edition=fundamental","pubTime":"2025-01-21 22:15","pubTimestamp":1737468952,"startTime":"0","endTime":"0","summary":"Keros Therapeutics  said Tuesday that it will receive a $200 million upfront payment from Takeda Pharmaceutical  in connection to a global development and commercialization license deal to advance elritercept.The license agreement with Takeda took effect on Jan. 16, the biopharmaceutical company said.Keros shares were up 5% and Takeda shares were edging 0.3% higher in recent premarket activity.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["KROS","TAK","BK4007","BK4139"],"gpt_icon":0},{"id":"2505126227","title":"Takeda Recognized as a Top Employer in Canada for Third Consecutive Year","url":"https://stock-news.laohu8.com/highlight/detail?id=2505126227","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505126227?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464400,"startTime":"0","endTime":"0","summary":"Recognition Reinforces Commitment to Creating an Exceptional People Experience. TORONTO, Jan. 21, 2025 /CNW/-Today,Takeda Canada Inc. announced that, for the third consecutive year, it has received Top Employer certification for 2025. Takeda is one of just 17 companies that received global recognition, and it also was certified as a Top Employer in 24 countries.About Takeda Canada Inc.Takeda Canada Inc. is the Canadian organization of Takeda Pharmaceutical Company Limited . Takeda is focused on creating better health for people and a brighter future for the world. We aim to discover and deliver life-transforming treatments in our core therapeutic and business areas, including gastrointestinal and inflammation, rare diseases, plasma-derived therapies, oncology, neuroscience, and vaccines. Together with our partners, we aim to improve the patient experience and advance a new frontier of treatment options through our dynamic and diverse pipeline. As a leading values-based, R\\&D-driven bio","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-recognized-top-employer-canada-130000041.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2505122718","title":"Keros Therapeutics Announces Effectiveness of Global License Agreement with Takeda to Advance Elritercept","url":"https://stock-news.laohu8.com/highlight/detail?id=2505122718","media":"GlobeNewswire","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505122718?lang=en_us&edition=fundamental","pubTime":"2025-01-21 21:00","pubTimestamp":1737464400,"startTime":"0","endTime":"0","summary":"LEXINGTON, Mass., Jan. 21, 2025  -- Keros Therapeutics, Inc.  , a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapeutics to treat a wide range of patients with disorders that are linked to dysfunctional signaling of the transforming growth factor-beta  family of proteins, today announced that the global development and commercialization license agreement with Takeda  to advance elritercept became effective on January 16, 2025. The agreement, which was previously announced on December 3, 2024, became effective upon the expiration or termination of the applicable waiting period under the Hart-Scott Rodino Antitrust Improvements Act of 1976, as amended. In connection with the effectiveness of the agreement, Takeda will make an upfront payment to the Company of $200.0 million.","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/keros-therapeutics-announces-effectiveness-global-130000001.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LENZ","BK4007","KROS","BK4139","TAK"],"gpt_icon":0},{"id":"2505498792","title":"Takeda Canada Says Health Canada Granted Market Authorization for Fruzaqla","url":"https://stock-news.laohu8.com/highlight/detail?id=2505498792","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2505498792?lang=en_us&edition=fundamental","pubTime":"2025-01-21 17:40","pubTimestamp":1737452409,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical's  Takeda Canada said Monday that Health Canada has provided market authorization for Fruzaqla for the treatment of certain adult patients with metastatic colorectal cancer.The authorization is based on data from two phase 3 trials in which Fruzaqla plus best supportive care showed \"significant improvements in overall survival,\" with corresponding improvements in progression free survival, compared with placebo, the company said.","market":"sg","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["TAK","BK4007"],"gpt_icon":0},{"id":"2504288791","title":"Takeda's FRUZAQLA™ (fruquintinib) Receives Health Canada Market Authorization for Metastatic Colorectal Cancer (mCRC)","url":"https://stock-news.laohu8.com/highlight/detail?id=2504288791","media":"CNW Group","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2504288791?lang=en_us&edition=fundamental","pubTime":"2025-01-20 21:00","pubTimestamp":1737378000,"startTime":"0","endTime":"0","summary":"TORONTO, Jan. 20, 2025 /CNW/ -Takeda Canada Inc.  is pleased to announce that Health Canada has provided market authorization for FRUZAQLA, indicated for the treatment of adult patients with metastatic colorectal cancer  who have been previously treated with or are not considered candidates for available standard therapies, including fluoropyrimidine-, oxaliplatin-, and irinotecan-based chemotherapy, an anti-VEGF agent, an anti-EGFR agent , and either trifluridine-tipiracil or regorafenib.1. This was followed by positive reimbursement recommendations by Canada's Drug Agency  and Institut national d'excellence en santé et services sociaux .FRUZAQLA works by helping to stop tumors from making new blood vessels and therefore slowing down the growth of cancer.1. An estimated 25,200 Canadians will be diagnosed with colorectal cancer in 2024, representing 10 per cent of all new cancer cases. 4,5 It is the second leading cause of death from cancer in men and the third leading cause of death f","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takedas-fruzaqla-fruquintinib-receives-health-130000082.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4213","TAK","BK4007","LU0266512127.USD","CRC","LU0456854461.SGD"],"gpt_icon":0},{"id":"2502281228","title":"ADMA Stock Catapults 275.7% in a Year: How Should You Play the Stock?","url":"https://stock-news.laohu8.com/highlight/detail?id=2502281228","media":"Zacks","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2502281228?lang=en_us&edition=fundamental","pubTime":"2025-01-11 02:41","pubTimestamp":1736534460,"startTime":"0","endTime":"0","summary":"ADMA Biologics ADMA shares have skyrocketed 275.7% in a year against the industry’s decline of 14.3%. The stock has also outperformed the sector and the S&P 500 during the aforementioned period.ADMA also hit a 52-week high of $23.64 on Nov. 11. The stupendous rally can be attributed to the company’s consistently strong quarterly performance and raised guidance.ADMA Biologics markets plasma-derived biologics for the treatment of immune deficiencies and the prevention of certain infectious diseases.The company’s top line currently comprises sales of three FDA-approved products — Bivigam , Asceniv  and Nabi-HB .While reporting third-quarter results, ADMA raised its outlook for 2024 and 2025 once again. ADMA now expects to generate revenues of more than $415 million in 2024 and $465 million in 2025 . Net income is projected to exceed $120 million in 2024 and $165 million in 2025 .ADMA’s higher-margin product portfolio now accounts for more than 50%","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/adma-stock-catapults-275-7-184100433.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","GRFS","ADMA","BK4139","TAK"],"gpt_icon":0},{"id":"2500211749","title":"Verizon Frontline showcases advanced communications solutions at EDGE25","url":"https://stock-news.laohu8.com/highlight/detail?id=2500211749","media":"GlobeNewswire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2500211749?lang=en_us&edition=fundamental","pubTime":"2025-01-02 22:00","pubTimestamp":1735826400,"startTime":"0","endTime":"0","summary":"The EDGE25 keynote will be delivered by Verizon Frontline and the U.S. Secret ServiceLAS VEGAS, Jan.  02, 2025  (GLOBE NEWSWIRE) -- Verizon Frontline will demonstrate several innovative solutions desi","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.globenewswire.com/news-release/2025/01/02/3003561/0/en/Verizon-Frontline-showcases-advanced-communications-solutions-at-EDGE25.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1430594728.SGD","BK4588","LU1066051811.HKD","LU1621768206.USD","LU0321505439.SGD","VZ","LU1066051225.USD","LU0306806265.USD","LU1621767810.EUR","LU1066051498.USD","LU1066053197.SGD","BK4534","LU0098860793.USD","BK4007","LU0868494617.USD","LU0225284248.USD","LU1571399168.USD","TAK","BK4533","LU1585245621.USD","LU1914381329.SGD","BK4115","IE00BSNM7G36.USD","LU1162221912.USD","LU1366192091.USD","BK4559","LU0306807586.USD","BK4550","LU2384288077.EUR","LU0985481810.HKD","BK4515","LU1699723380.USD","LU1621768115.EUR","BK4581","LU0868494708.USD","LU0942090050.USD","LU0321505868.SGD","LU0320765646.SGD","BK4585","LU1621767737.EUR","LU0225771236.USD"],"gpt_icon":0},{"id":"2494383980","title":"Sector Update: Health Care Stocks Mixed Pre-Bell Friday","url":"https://stock-news.laohu8.com/highlight/detail?id=2494383980","media":"MT Newswires Live","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494383980?lang=en_us&edition=fundamental","pubTime":"2024-12-27 22:05","pubTimestamp":1735308314,"startTime":"0","endTime":"0","summary":"Health care stocks were mixed pre-bell Friday as the iShares Biotechnology ETF (IBB) was 0.1% higher and the Health Care Select Sector SPDR Fund (XLV) was down 0.2% recently.UnitedHealth Group (UNH) a","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["LU1778281490.HKD","LU1814569148.SGD","LU0354030511.USD","LU2361045086.USD","LU0198837287.USD","LU0149725797.USD","LU0079474960.USD","IE00B1XK9C88.USD","IE00B4R5TH58.HKD","XLV","LU2361044865.SGD","SG9999014898.SGD","LU0310800379.SGD","IE0002270589.USD","IE0004445015.USD","IE00BFSS8Q28.SGD","LU2111349929.HKD","SG9999001176.SGD","SGXZ51526630.SGD","LU1066051811.HKD","LU1496350502.SGD","LU1069347547.HKD","LU0820561818.USD","LU1854103824.USD","LU2347655156.SGD","IBB","UNH","AMED","LU2211815571.USD","IE00B4JS1V06.HKD","LU1934455277.USD","IE00BN29S564.USD","LU2089984988.USD","LU0289739699.SGD","LU0158827948.USD","LU0672654240.SGD","LU0077335932.USD","LU1074936037.SGD","LU0251132253.USD","LU0320765059.SGD","IE00B19Z9505.USD","LU0417517546.SGD","LU1003077747.HKD","TAK","LU0553294199.USD","XCUR","LU1267930730.SGD","LU0345770308.USD","LU2357305700.SGD","LU0211328371.USD"],"gpt_icon":1},{"id":"2494117388","title":"Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency","url":"https://stock-news.laohu8.com/highlight/detail?id=2494117388","media":"Benzinga","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494117388?lang=en_us&edition=fundamental","pubTime":"2024-12-27 20:59","pubTimestamp":1735304385,"startTime":"0","endTime":"0","summary":"These conditions, characterized by low or absent antibody levels, result in an increased risk of serious infections. This approval introduces the first and only facilitated subcutaneous immunoglobulin  therapy in Japan, offering patients a new treatment option.HYQVIA combines subcutaneous immunoglobulin (10%) with recombinant human hyaluronidase , which facilitates larger volume infusions by increasing the dispersion and absorption of immunoglobulin in subcutaneous tissue.Also Read: Bitcoin, Ethereum, Dogecoin Pull Back After Christmas Rally: Top Analyst Reveals What Happens Next After BTC Fails To Record Daily Close Above $100K. This allows for less frequent dosing, with treatments every 3 to 4 weeks, compared to weekly or bi-weekly infusions with other subcutaneous immunoglobulin treatments.This flexibility eliminates the need for venous access, offering patients greater convenience.The approval was based on data from two Phase 3 clinical trials conducted in Japan and North America.T","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takedas-hyqvia-approved-japan-treat-125945130.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":"Takeda's HYQVIA Approved in Japan To Treat Immunodeficiency","news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2494701838","title":"Takeda announces Japan MHLW approval for new Hyqvia use","url":"https://stock-news.laohu8.com/highlight/detail?id=2494701838","media":"TIPRANKS","labels":["policyRegulatory"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494701838?lang=en_us&edition=fundamental","pubTime":"2024-12-27 18:10","pubTimestamp":1735294208,"startTime":"0","endTime":"0","summary":"Takeda (TAK) announced that the Japanese Ministry of Health, Labour and Welfare has approved the use of Hyqvia in patients with agammaglobulinemia ...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/takeda-announces-japan-mhlw-approval-for-new-hyqvia-use?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/takeda-announces-japan-mhlw-approval-for-new-hyqvia-use?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"policyRegulatory","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2494876099","title":"Takeda Pharmaceutical's Hyqvia Approved in Japan for Patients With Immune Disorders","url":"https://stock-news.laohu8.com/highlight/detail?id=2494876099","media":"MT Newswires Live","labels":["productRelease"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2494876099?lang=en_us&edition=fundamental","pubTime":"2024-12-27 16:39","pubTimestamp":1735288778,"startTime":"0","endTime":"0","summary":"Takeda Pharmaceutical (TAK) said Friday that the Japanese Ministry of Health, Labor and Welfare has approved the use of Hyqvia in patients with agammaglobulinemia or hypogammaglobulinemia.The two rare","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.mtnewswires.com/","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"productRelease","news_rank":0,"length":0,"strategy_id":0,"source":"mtnewswires_news","symbols":["BK4007","TAK"],"gpt_icon":0},{"id":"2493424989","title":"TD Cowen Reaffirms Their Buy Rating on Takeda Pharmaceutical Company (TAK)","url":"https://stock-news.laohu8.com/highlight/detail?id=2493424989","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2493424989?lang=en_us&edition=fundamental","pubTime":"2024-12-21 01:40","pubTimestamp":1734716445,"startTime":"0","endTime":"0","summary":"In a report released yesterday, Michael Nedelcovych from TD Cowen maintained a Buy rating on Takeda Pharmaceutical Company (TAK – Research Report)....","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-takeda-pharmaceutical-company-tak?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/td-cowen-reaffirms-their-buy-rating-on-takeda-pharmaceutical-company-tak?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["TAK","TD","COWN"],"gpt_icon":0},{"id":"2492783911","title":"Takeda Sponsors MILESTONE Canada Advanced Inflammatory Bowel Disease (IBD) Fellowship Initiative","url":"https://stock-news.laohu8.com/highlight/detail?id=2492783911","media":"CNW Group","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492783911?lang=en_us&edition=fundamental","pubTime":"2024-12-19 21:02","pubTimestamp":1734613320,"startTime":"0","endTime":"0","summary":"Twenty Canadian Fellows Participate in the Inaugural Program. TORONTO, Dec. 19, 2024 /CNW/ - Takeda Canada Inc.  is proud to sponsor the Inaugural MILESTONE Canada Advanced Inflammatory Bowel Disease  Fellows Initiative. This program aims to standardize training, organize networks, and implement Entrustable Professional Activities  for advanced IBD fellows in Canada.\"The MILESTONE Canada Advanced IBD Fellows Initiative will enhance patient care and help improve outcomes in Canada,\" said Vatro Mateljic, General Manager, Takeda. \"This program reflects Takeda's commitment to advancing education and training to improve the lives of Canadians living with IBD.\". \"By offering this specialized training, we are ensuring that IBD fellows not only understand the complexities of the disease but also know how to provide the best possible care for patients from all walks of life,\" said Dr. Florian Rieder, Vice Chair, Co-Section Director Inflammatory Bowel Diseases, at the Cleveland Clinic Digestive ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/IM9OiDdbQN6uuNqzpUsKRQ--~B/aD0yMTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/ea9be5021f4f0d27aa1c56fa15d27a1a","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/IM9OiDdbQN6uuNqzpUsKRQ--~B/aD0yMTA7dz00MDA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/cnwgroup.com/ea9be5021f4f0d27aa1c56fa15d27a1a"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-sponsors-milestone-canada-advanced-130200426.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["CIRC","IBD","IE00B66KJ199.SGD","IE0031619046.USD","AEIS","TAK","IE00B19Z4B17.USD","IE00B7SZL793.SGD","BK4007","BK4157"],"gpt_icon":0},{"id":"2492126469","title":"Takeda Announces Subsidiary Liquidation and Merger Completion","url":"https://stock-news.laohu8.com/highlight/detail?id=2492126469","media":"TipRanks","labels":["corporation"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492126469?lang=en_us&edition=fundamental","pubTime":"2024-12-19 19:32","pubTimestamp":1734607946,"startTime":"0","endTime":"0","summary":"Discover top-rated stocks from highly ranked analysts with Analyst Top Stocks!Easily identify outperforming stocks and invest smarter with Top Smart Score Stocks. Takeda Pharmaceutical Company has submitted an extraordinary report detailing its decision to dissolve its specified subsidiary, Shire Pharmaceuticals International Unlimited Company, through liquidation. This move results in a significant change in the voting rights structure, marking the completion of a merger process where Takeda now holds no voting rights in the subsidiary. The liquidation process will follow local regulations, although the exact completion date is yet to be determined. This strategic decision reflects Takeda’s ongoing efforts to streamline its operations and focus on its core business areas.Takeda Pharmaceutical Company Limited is a global leader in the pharmaceutical industry, headquartered in Osaka, Japan. The company focuses on producing innovative medicines in areas such as oncology, gastroenterology","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/8UFfyvN5uwZovBLtL_6j3A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/bbad1dd12cc6ba90ddd83aeee03f1aae","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/8UFfyvN5uwZovBLtL_6j3A--~B/aD0xOTI7dz0xOTI7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/tipranks_452/bbad1dd12cc6ba90ddd83aeee03f1aae"],"rights":{"source":"yahoofinance","url":"https://finance.yahoo.com/news/takeda-announces-subsidiary-liquidation-merger-113226472.html","rn_cache_url":null,"customStyle":"img, svg { display: none !important; }","selectors":"article","filters":"","directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/takeda-announces-subsidiary-liquidation-merger-113226472.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":"Takeda Announces Subsidiary Liquidation and Merger Completion","news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["TAK","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":4,"pageCount":3,"totalSize":80,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/TAK\",params:#limit:5,,,undefined,":[{"date":"2025-05-08","symbol":"TAK","type":"earning","reportTimeType":"pre","market":"US","fiscalQuarterEnding":"2025/03","expectedEps":null,"defaultRemindTime":1746691200000,"name":null,"time":"Pre-Market","dateTimestamp":1746676800000,"actualEps":null},{"market":"US","date":"2025-01-30","symbol":"TAK","fiscalQuarterEnding":"2024/12","expectedEps":0.34,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1738213200000,"reportTimeType":"pre","actualEps":0.42},{"market":"US","date":"2024-10-31","symbol":"TAK","fiscalQuarterEnding":"2024/09","expectedEps":0.39,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1730347200000,"reportTimeType":"pre","actualEps":0.44},{"market":"US","date":"2024-07-31","symbol":"TAK","fiscalQuarterEnding":"2024/06","expectedEps":0.37,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1722398400000,"reportTimeType":"pre","actualEps":0.56},{"market":"US","date":"2024-05-09","symbol":"TAK","fiscalQuarterEnding":"2024/03","expectedEps":null,"name":null,"time":"Pre-Market","type":"earning","dateTimestamp":1715227200000,"reportTimeType":"pre","actualEps":0}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"TAK\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"TAK\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.5,"hold":0.25,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.5,"analysts":4,"updateTime":1689307200000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/TAK\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"TAK","date":"2025-05-02","current":32.102637,"percent":0.59854,"low":9.919003,"twenty":15.728527,"median":29.784868,"eighty":45.020529,"high":448.636969,"avg":39.189931,"sd":42.600526,"marketCap":45944348076.13},"quantilePoints":[{"date":"2020-05-08","current":438.427339,"twenty":25.784378,"median":36.398869,"eighty":81.931076,"marketCap":54638780722.19},{"date":"2020-05-15","current":141.266146,"twenty":25.78995,"median":36.47458,"eighty":82.305276,"marketCap":58229887273.26},{"date":"2020-05-22","current":142.498528,"twenty":25.895823,"median":36.514941,"eighty":82.473666,"marketCap":58640622164.25},{"date":"2020-05-29","current":147.568898,"twenty":26.094305,"median":36.5454,"eighty":82.720638,"marketCap":60618343666.07},{"date":"2020-06-05","current":142.287262,"twenty":26.802799,"median":36.578836,"eighty":82.960126,"marketCap":57369545717.84},{"date":"2020-06-12","current":140.456295,"twenty":26.987384,"median":36.601121,"eighty":83.356777,"marketCap":57891751795.22},{"date":"2020-06-19","current":141.688677,"twenty":27.833349,"median":36.617455,"eighty":83.603749,"marketCap":58614309903.35},{"date":"2020-06-26","current":139.787288,"twenty":28.382494,"median":36.66065,"eighty":84.02269,"marketCap":57689640075.75},{"date":"2020-07-02","current":134.083122,"twenty":28.490627,"median":36.703774,"eighty":84.187418,"marketCap":55151885879.75},{"date":"2020-07-10","current":129.224017,"twenty":28.584436,"median":36.784141,"eighty":85.31532,"marketCap":53543496364.44},{"date":"2020-07-17","current":130.667664,"twenty":28.683495,"median":36.800541,"eighty":86.385434,"marketCap":53972328180.49},{"date":"2020-07-24","current":133.164486,"twenty":28.804715,"median":36.81694,"eighty":87.725687,"marketCap":55658397179.21},{"date":"2020-07-31","current":49.030087,"twenty":28.880318,"median":36.830882,"eighty":88.33002,"marketCap":55557224542.23},{"date":"2020-08-07","current":49.695831,"twenty":29.000288,"median":36.883572,"eighty":88.247168,"marketCap":56220621340.2},{"date":"2020-08-14","current":51.954139,"twenty":29.120238,"median":36.973174,"eighty":88.149695,"marketCap":58424376584.77},{"date":"2020-08-21","current":52.698206,"twenty":29.210125,"median":37.019329,"eighty":87.725687,"marketCap":59589605364.98},{"date":"2020-08-28","current":51.875816,"twenty":29.296114,"median":37.194931,"eighty":87.39428,"marketCap":59006258563.45},{"date":"2020-09-04","current":50.217983,"twenty":29.358735,"median":37.349685,"eighty":86.853304,"marketCap":56544754820.4},{"date":"2020-09-11","current":51.079534,"twenty":29.413482,"median":37.496711,"eighty":86.502401,"marketCap":57600970548.14},{"date":"2020-09-18","current":52.071623,"twenty":29.482546,"median":37.644832,"eighty":86.409802,"marketCap":59718536367.45},{"date":"2020-09-25","current":51.23618,"twenty":29.528429,"median":37.70687,"eighty":86.307455,"marketCap":58079537631.11},{"date":"2020-10-02","current":47.267823,"twenty":29.55872,"median":37.818162,"eighty":86.127131,"marketCap":53733241411.92},{"date":"2020-10-09","current":48.45572,"twenty":29.570204,"median":38.056274,"eighty":85.695464,"marketCap":54928745380.19},{"date":"2020-10-16","current":45.740528,"twenty":29.581756,"median":38.101028,"eighty":85.328548,"marketCap":51955606617.4},{"date":"2020-10-23","current":45.688313,"twenty":29.610527,"median":38.151519,"eighty":85.068348,"marketCap":52213782354.12},{"date":"2020-10-30","current":90.341121,"twenty":29.668895,"median":38.172466,"eighty":85.328548,"marketCap":48419952386.27},{"date":"2020-11-06","current":96.588856,"twenty":29.692357,"median":38.217233,"eighty":86.409802,"marketCap":52398853598.67},{"date":"2020-11-13","current":100.410015,"twenty":29.692593,"median":38.315348,"eighty":87.847529,"marketCap":53780559103.29},{"date":"2020-11-20","current":101.776706,"twenty":29.697927,"median":38.413443,"eighty":88.520092,"marketCap":54951029488.93},{"date":"2020-11-27","current":104.091715,"twenty":29.726253,"median":38.431569,"eighty":89.212151,"marketCap":56090722051.49},{"date":"2020-12-04","current":108.749624,"twenty":29.809673,"median":41.476727,"eighty":89.840851,"marketCap":58500568009.94},{"date":"2020-12-11","current":107.940766,"twenty":29.825396,"median":42.195512,"eighty":90.113776,"marketCap":58227511975.44},{"date":"2020-12-18","current":108.136007,"twenty":29.898634,"median":42.406568,"eighty":90.568631,"marketCap":58641544051.05},{"date":"2020-12-24","current":104.063823,"twenty":29.940017,"median":42.671516,"eighty":90.966664,"marketCap":56275869966.77},{"date":"2020-12-31","current":104.733224,"twenty":29.971299,"median":42.851076,"eighty":91.332188,"marketCap":56879881356.69},{"date":"2021-01-08","current":103.059723,"twenty":29.97912,"median":42.920583,"eighty":91.791488,"marketCap":55589135003.46},{"date":"2021-01-15","current":100.437906,"twenty":29.989622,"median":43.181235,"eighty":92.111972,"marketCap":54236546808.57},{"date":"2021-01-22","current":100.047423,"twenty":30.031602,"median":43.418717,"eighty":92.258181,"marketCap":54029329143.49},{"date":"2021-01-29","current":103.143398,"twenty":30.073173,"median":43.598578,"eighty":92.394644,"marketCap":55216620705.7},{"date":"2021-02-05","current":31.781037,"twenty":30.157692,"median":43.665039,"eighty":92.535979,"marketCap":54432227223.55},{"date":"2021-02-12","current":31.919516,"twenty":30.223066,"median":43.441886,"eighty":92.526232,"marketCap":54935581599.54},{"date":"2021-02-19","current":31.997411,"twenty":30.238705,"median":43.337626,"eighty":92.438506,"marketCap":54757645997.71},{"date":"2021-02-26","current":31.00209,"twenty":30.269781,"median":42.961129,"eighty":92.297171,"marketCap":52506642547.95},{"date":"2021-03-05","current":32.525364,"twenty":30.307584,"median":42.874245,"eighty":92.272802,"marketCap":54273339139.55},{"date":"2021-03-12","current":34.741035,"twenty":30.314105,"median":42.671516,"eighty":92.258181,"marketCap":57572160306.5},{"date":"2021-03-19","current":36.991326,"twenty":30.320622,"median":42.376112,"eighty":92.258181,"marketCap":61377881020.81},{"date":"2021-03-26","current":36.385479,"twenty":30.34278,"median":42.069006,"eighty":92.219192,"marketCap":59972674222.12},{"date":"2021-04-01","current":35.38287,"twenty":30.371454,"median":41.476727,"eighty":92.150961,"marketCap":57783874962.89},{"date":"2021-04-09","current":32.481215,"twenty":30.393667,"median":38.431569,"eighty":92.111972,"marketCap":53478879478.89},{"date":"2021-04-16","current":32.082779,"twenty":30.470959,"median":38.377853,"eighty":92.111972,"marketCap":53250001858.4},{"date":"2021-04-23","current":31.900884,"twenty":30.513064,"median":38.294386,"eighty":92.058362,"marketCap":53341682665.94},{"date":"2021-04-30","current":31.485125,"twenty":30.533079,"median":38.21414,"eighty":91.833434,"marketCap":52029509066.16},{"date":"2021-05-07","current":31.831591,"twenty":30.534382,"median":38.169603,"eighty":91.791488,"marketCap":52970833572.63},{"date":"2021-05-14","current":15.564762,"twenty":30.470959,"median":38.145677,"eighty":91.758112,"marketCap":53496176267.97},{"date":"2021-05-21","current":15.876889,"twenty":30.319318,"median":38.091991,"eighty":91.609986,"marketCap":54795356598.76},{"date":"2021-05-28","current":15.664642,"twenty":30.236167,"median":38.041392,"eighty":91.546628,"marketCap":53587690959.61},{"date":"2021-06-04","current":15.281766,"twenty":30.057838,"median":37.818162,"eighty":91.527134,"marketCap":52499044333.6},{"date":"2021-06-11","current":15.732274,"twenty":29.940017,"median":37.70687,"eighty":91.283451,"marketCap":53886220157.49},{"date":"2021-06-18","current":15.499142,"twenty":29.705398,"median":37.644832,"eighty":91.259083,"marketCap":52855138856.99},{"date":"2021-06-25","current":15.64495,"twenty":29.653254,"median":37.496711,"eighty":91.185978,"marketCap":53110087882.29},{"date":"2021-07-02","current":15.624135,"twenty":29.556114,"median":37.309512,"eighty":90.966664,"marketCap":52790633079.89},{"date":"2021-07-09","current":15.170356,"twenty":29.369182,"median":37.239049,"eighty":90.713234,"marketCap":51765371608.86},{"date":"2021-07-16","current":15.553362,"twenty":29.036801,"median":37.034171,"eighty":90.649877,"marketCap":53089153550.44},{"date":"2021-07-23","current":15.445121,"twenty":28.610503,"median":36.990446,"eighty":90.630383,"marketCap":52540828243.5},{"date":"2021-07-30","current":13.400212,"twenty":26.987384,"median":36.968687,"eighty":90.397999,"marketCap":52641482781.37},{"date":"2021-08-06","current":13.231512,"twenty":25.788836,"median":36.881192,"eighty":90.295707,"marketCap":51739766156.6},{"date":"2021-08-13","current":13.399277,"twenty":25.542527,"median":36.851251,"eighty":90.284353,"marketCap":52624385513.69},{"date":"2021-08-20","current":13.340924,"twenty":25.375364,"median":36.822486,"eighty":90.167386,"marketCap":52391869685.63},{"date":"2021-08-27","current":13.304453,"twenty":25.07978,"median":36.81694,"eighty":90.040671,"marketCap":52184954198.97},{"date":"2021-09-03","current":13.585277,"twenty":24.895379,"median":36.800541,"eighty":89.938325,"marketCap":53414238064.1},{"date":"2021-09-10","current":13.6801,"twenty":24.732641,"median":36.787118,"eighty":89.91883,"marketCap":53684261064.92},{"date":"2021-09-17","current":13.906217,"twenty":24.583535,"median":36.72461,"eighty":89.874967,"marketCap":54565644835.19},{"date":"2021-09-24","current":13.753041,"twenty":24.444102,"median":36.66065,"eighty":89.831104,"marketCap":53563443001.25},{"date":"2021-10-01","current":13.260689,"twenty":24.187434,"median":36.617455,"eighty":89.777494,"marketCap":51482210756.95},{"date":"2021-10-08","current":11.666926,"twenty":23.93319,"median":36.601121,"eighty":89.748252,"marketCap":44862900501.13},{"date":"2021-10-15","current":11.787279,"twenty":23.7033,"median":36.578836,"eighty":89.499696,"marketCap":44516597060.99},{"date":"2021-10-22","current":11.681514,"twenty":23.539863,"median":36.5454,"eighty":88.968468,"marketCap":44293684279.19},{"date":"2021-10-29","current":10.648321,"twenty":23.423498,"median":36.488155,"eighty":88.710165,"marketCap":44164269191.12},{"date":"2021-11-05","current":10.784625,"twenty":23.226892,"median":36.468627,"eighty":88.627312,"marketCap":44983557825.66},{"date":"2021-11-12","current":10.950849,"twenty":22.951173,"median":36.398869,"eighty":88.490851,"marketCap":45493195113.2},{"date":"2021-11-19","current":10.728109,"twenty":22.593579,"median":36.365388,"eighty":88.33002,"marketCap":44596449686.83},{"date":"2021-11-26","current":10.425581,"twenty":22.055183,"median":36.25968,"eighty":88.252042,"marketCap":43512424769.26},{"date":"2021-12-03","current":10.106651,"twenty":21.515452,"median":36.172679,"eighty":88.178937,"marketCap":42286529642.36},{"date":"2021-12-10","current":10.142864,"twenty":21.321368,"median":36.088488,"eighty":87.847529,"marketCap":42348534488.31},{"date":"2021-12-17","current":10.34424,"twenty":21.015505,"median":36.02197,"eighty":87.423521,"marketCap":43082485607.36},{"date":"2021-12-23","current":10.363994,"twenty":20.795645,"median":35.82744,"eighty":87.174965,"marketCap":42874132957.12},{"date":"2021-12-31","current":10.327779,"twenty":20.657578,"median":35.632629,"eighty":86.517022,"marketCap":42437110052.52},{"date":"2022-01-07","current":10.522022,"twenty":20.640925,"median":35.562823,"eighty":86.434171,"marketCap":43033429977.32},{"date":"2022-01-14","current":11.009273,"twenty":20.536864,"median":35.556871,"eighty":86.322076,"marketCap":45750368973.66},{"date":"2022-01-21","current":10.940136,"twenty":20.171308,"median":35.520843,"eighty":86.263593,"marketCap":45488233052.08},{"date":"2022-01-28","current":10.953305,"twenty":19.949589,"median":35.455688,"eighty":85.922437,"marketCap":44994125510.56},{"date":"2022-02-04","current":12.019761,"twenty":19.86233,"median":35.393845,"eighty":85.355005,"marketCap":45736794370.02},{"date":"2022-02-11","current":12.502153,"twenty":19.831282,"median":35.308236,"eighty":85.302091,"marketCap":47298200126.65},{"date":"2022-02-18","current":12.558981,"twenty":19.671006,"median":35.308236,"eighty":85.302091,"marketCap":47834673171.52},{"date":"2022-02-25","current":12.196703,"twenty":19.550551,"median":35.308236,"eighty":85.302091,"marketCap":46263555485.74},{"date":"2022-03-04","current":12.289048,"twenty":19.380891,"median":35.308236,"eighty":85.302091,"marketCap":46976698663.99},{"date":"2022-03-11","current":12.043978,"twenty":19.117196,"median":35.308236,"eighty":85.302091,"marketCap":45095629553.81},{"date":"2022-03-18","current":12.707196,"twenty":18.980245,"median":35.308236,"eighty":85.302091,"marketCap":46769031069.82},{"date":"2022-03-25","current":12.770838,"twenty":18.858799,"median":35.308236,"eighty":85.302091,"marketCap":45895036970.15},{"date":"2022-04-01","current":12.530413,"twenty":18.69121,"median":35.308236,"eighty":85.302091,"marketCap":44742437445.66},{"date":"2022-04-08","current":13.064299,"twenty":18.623126,"median":35.308236,"eighty":85.302091,"marketCap":46073289723.14},{"date":"2022-04-14","current":13.294114,"twenty":18.443795,"median":35.308236,"eighty":85.302091,"marketCap":46294767383.12},{"date":"2022-04-22","current":13.21633,"twenty":18.221438,"median":35.308236,"eighty":85.302091,"marketCap":45025239824.55},{"date":"2022-04-29","current":13.325935,"twenty":17.979017,"median":35.308236,"eighty":85.302091,"marketCap":45022632781.95},{"date":"2022-05-06","current":13.53454,"twenty":17.700642,"median":35.308236,"eighty":85.302091,"marketCap":45566277364},{"date":"2022-05-13","current":24.629857,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":43848144051.53},{"date":"2022-05-20","current":25.018997,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45016426783.75},{"date":"2022-05-27","current":25.119636,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":45470626890.48},{"date":"2022-06-03","current":24.280973,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":42728413394.89},{"date":"2022-06-10","current":24.368194,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":41777808638.38},{"date":"2022-06-17","current":23.83145,"twenty":15.872727,"median":35.308236,"eighty":85.302091,"marketCap":40560767412.66},{"date":"2022-06-24","current":24.871564,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42352646298.73},{"date":"2022-07-01","current":25.220478,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":42911856821.29},{"date":"2022-07-08","current":26.059148,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44046297256.04},{"date":"2022-07-15","current":26.763631,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":44459950529.79},{"date":"2022-07-22","current":26.817305,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45321441244.41},{"date":"2022-07-29","current":30.743571,"twenty":15.868566,"median":35.321487,"eighty":85.31532,"marketCap":45477961048.28},{"date":"2022-08-05","current":29.247514,"twenty":15.868566,"median":35.251678,"eighty":85.31532,"marketCap":42639852719.36},{"date":"2022-08-12","current":29.748811,"twenty":15.868566,"median":35.071486,"eighty":85.31532,"marketCap":43951767417.68},{"date":"2022-08-19","current":29.8898,"twenty":15.868566,"median":34.741035,"eighty":85.31532,"marketCap":43038704613},{"date":"2022-08-26","current":29.874135,"twenty":15.868566,"median":33.797644,"eighty":85.31532,"marketCap":42969756201.7},{"date":"2022-09-02","current":30.022957,"twenty":15.868566,"median":32.525364,"eighty":85.31532,"marketCap":42304023842.38},{"date":"2022-09-09","current":30.65741,"twenty":15.868566,"median":32.307982,"eighty":85.31532,"marketCap":42457872052.31},{"date":"2022-09-16","current":30.406762,"twenty":15.868566,"median":32.13589,"eighty":85.31532,"marketCap":41975860478.2},{"date":"2022-09-23","current":29.784868,"twenty":15.868566,"median":32.082779,"eighty":85.31532,"marketCap":41053322910.74},{"date":"2022-09-30","current":29.611929,"twenty":15.868566,"median":31.991351,"eighty":85.31532,"marketCap":40398024705.55},{"date":"2022-10-07","current":29.784868,"twenty":15.868566,"median":31.910861,"eighty":85.31532,"marketCap":40490115913.28},{"date":"2022-10-14","current":30.091442,"twenty":15.868566,"median":31.822929,"eighty":85.31532,"marketCap":40007811364.69},{"date":"2022-10-21","current":29.234607,"twenty":15.868566,"median":31.680102,"eighty":85.31532,"marketCap":38943108088.84},{"date":"2022-10-28","current":27.96678,"twenty":15.868566,"median":31.562866,"eighty":85.31532,"marketCap":40412932074.34},{"date":"2022-11-04","current":27.990228,"twenty":15.868566,"median":31.51076,"eighty":85.31532,"marketCap":40544936411.09},{"date":"2022-11-11","current":28.209015,"twenty":15.868566,"median":31.374814,"eighty":85.31532,"marketCap":43206259311.05},{"date":"2022-11-18","current":28.704934,"twenty":15.868566,"median":31.254645,"eighty":85.31532,"marketCap":43730486647.27},{"date":"2022-11-25","current":29.426933,"twenty":15.868566,"median":31.201154,"eighty":85.31532,"marketCap":45057111010.77},{"date":"2022-12-02","current":28.931014,"twenty":15.868566,"median":31.037761,"eighty":85.31532,"marketCap":45570767384.44},{"date":"2022-12-09","current":29.835336,"twenty":15.868566,"median":30.937343,"eighty":85.31532,"marketCap":46637499358.3},{"date":"2022-12-16","current":30.331255,"twenty":15.868566,"median":30.871973,"eighty":85.31532,"marketCap":47313819017.43},{"date":"2022-12-23","current":29.900973,"twenty":15.868566,"median":30.772934,"eighty":85.31532,"marketCap":47996239753.01},{"date":"2022-12-30","current":29.981195,"twenty":15.868566,"median":30.71556,"eighty":85.31532,"marketCap":48463304453.77},{"date":"2023-01-06","current":29.755114,"twenty":15.868566,"median":30.572454,"eighty":85.31532,"marketCap":47870974965.36},{"date":"2023-01-13","current":29.864508,"twenty":15.868566,"median":30.484406,"eighty":85.31532,"marketCap":49882681588.13},{"date":"2023-01-20","current":30.426063,"twenty":15.868566,"median":30.426063,"eighty":85.31532,"marketCap":49943652563.58},{"date":"2023-01-27","current":30.148932,"twenty":15.868566,"median":30.406762,"eighty":85.31532,"marketCap":49467797966.47},{"date":"2023-02-03","current":23.618692,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49524315647.28},{"date":"2023-02-10","current":23.884908,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":49885153889.85},{"date":"2023-02-17","current":23.681054,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48373362782.36},{"date":"2023-02-24","current":23.799969,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":47942402215.74},{"date":"2023-03-03","current":24.043461,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":48450666632.88},{"date":"2023-03-10","current":24.621048,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50074775527.78},{"date":"2023-03-17","current":24.802252,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51520828536.51},{"date":"2023-03-24","current":24.139732,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50698940566.02},{"date":"2023-03-31","current":24.63238,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":50868882296.85},{"date":"2023-04-06","current":24.898523,"twenty":15.872727,"median":30.373407,"eighty":85.302091,"marketCap":51908951328.51},{"date":"2023-04-14","current":25.289243,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52430478946.56},{"date":"2023-04-21","current":25.436471,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52090554629.18},{"date":"2023-04-28","current":25.549723,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":52360758781.69},{"date":"2023-05-05","current":25.934781,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":53114594501.1},{"date":"2023-05-12","current":21.816188,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":51463307525.88},{"date":"2023-05-19","current":21.919152,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50148262100.11},{"date":"2023-05-26","current":22.174322,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50264110513.18},{"date":"2023-06-02","current":21.909524,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50016322403.86},{"date":"2023-06-09","current":22.247876,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50740318667.02},{"date":"2023-06-16","current":22.419504,"twenty":15.868566,"median":30.376663,"eighty":85.31532,"marketCap":50575421543.16},{"date":"2023-06-23","current":22.547244,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":50034367985.85},{"date":"2023-06-30","current":22.199081,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48652831553.96},{"date":"2023-07-07","current":21.625347,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47542321682.04},{"date":"2023-07-14","current":21.105555,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48436114801.39},{"date":"2023-07-21","current":21.512562,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":48597606707.51},{"date":"2023-07-28","current":22.302484,"twenty":15.864404,"median":30.386777,"eighty":85.328548,"marketCap":47655983749.28},{"date":"2023-08-04","current":22.405905,"twenty":15.864404,"median":30.349157,"eighty":85.328548,"marketCap":47472091400.73},{"date":"2023-08-11","current":22.962958,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47925971293.26},{"date":"2023-08-18","current":22.653484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":46744998549.67},{"date":"2023-08-25","current":22.947484,"twenty":15.864404,"median":30.308236,"eighty":85.328548,"marketCap":47472892956.93},{"date":"2023-09-01","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":48142626644.03},{"date":"2023-09-08","current":23.262116,"twenty":15.864404,"median":30.265696,"eighty":85.328548,"marketCap":47619131084.19},{"date":"2023-09-15","current":25.06738,"twenty":15.864404,"median":30.239629,"eighty":85.328548,"marketCap":51339735089.9},{"date":"2023-09-22","current":24.298853,"twenty":15.864404,"median":30.152523,"eighty":85.328548,"marketCap":49671905160.78},{"date":"2023-09-29","current":23.9378,"twenty":15.864404,"median":30.101284,"eighty":85.328548,"marketCap":48306094881.06},{"date":"2023-10-06","current":23.12801,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":46912236069.61},{"date":"2023-10-13","current":23.4478,"twenty":15.864404,"median":30.064639,"eighty":85.328548,"marketCap":47185225879.19},{"date":"2023-10-20","current":22.447168,"twenty":15.864404,"median":30.035164,"eighty":85.328548,"marketCap":45133632614.81},{"date":"2023-10-27","current":33.018744,"twenty":15.848805,"median":30.061417,"eighty":85.468491,"marketCap":42045438777.36},{"date":"2023-11-03","current":33.977052,"twenty":15.848805,"median":30.109117,"eighty":85.468491,"marketCap":43262280273.82},{"date":"2023-11-10","current":34.001614,"twenty":15.848805,"median":30.156114,"eighty":85.468491,"marketCap":43146195810.29},{"date":"2023-11-17","current":34.509223,"twenty":15.848805,"median":30.265619,"eighty":85.468491,"marketCap":43924997173.45},{"date":"2023-11-24","current":34.411351,"twenty":15.848805,"median":30.338548,"eighty":85.468491,"marketCap":44071202551.42},{"date":"2023-12-01","current":34.149357,"twenty":15.848805,"median":30.406762,"eighty":85.468491,"marketCap":44271809028.5},{"date":"2023-12-08","current":33.224188,"twenty":15.856081,"median":30.46982,"eighty":85.355005,"marketCap":44164475676.92},{"date":"2023-12-15","current":32.708387,"twenty":15.856081,"median":30.676992,"eighty":85.355005,"marketCap":44261463171.18},{"date":"2023-12-22","current":32.732997,"twenty":15.856081,"median":31.207345,"eighty":85.355005,"marketCap":44132705649.12},{"date":"2023-12-29","current":33.191488,"twenty":15.848805,"median":31.270394,"eighty":85.468491,"marketCap":45078827041.22},{"date":"2024-01-05","current":35.107326,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46553386498.52},{"date":"2024-01-12","current":35.467569,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46529118760.4},{"date":"2024-01-19","current":35.574004,"twenty":15.834252,"median":31.485125,"eighty":85.695464,"marketCap":46054562134.98},{"date":"2024-01-26","current":35.287452,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45813893702.51},{"date":"2024-02-02","current":37.669312,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":45919514328.61},{"date":"2024-02-09","current":37.493246,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":44733412617.38},{"date":"2024-02-16","current":38.84015,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46075141205.13},{"date":"2024-02-23","current":39.033823,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":46211688108.13},{"date":"2024-03-01","current":38.637675,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45954550562.52},{"date":"2024-03-08","current":38.311953,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":46140815426.08},{"date":"2024-03-15","current":37.871788,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45561442683.96},{"date":"2024-03-22","current":38.796134,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":45585981704.56},{"date":"2024-03-28","current":37.000261,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":43584427473.65},{"date":"2024-04-05","current":36.269795,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42616375994.67},{"date":"2024-04-12","current":36.498683,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":42430179712.64},{"date":"2024-04-19","current":35.820825,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":41294416133.79},{"date":"2024-04-26","current":35.997119,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41249770241.05},{"date":"2024-05-03","current":36.314041,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42076379836.26},{"date":"2024-05-10","current":36.349255,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41627594417.07},{"date":"2024-05-17","current":44.976968,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41733682877.63},{"date":"2024-05-24","current":45.020529,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41285104836.56},{"date":"2024-05-31","current":45.445251,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41787899615.91},{"date":"2024-06-07","current":46.087779,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":42554175847.16},{"date":"2024-06-14","current":45.107651,"twenty":15.848805,"median":31.485125,"eighty":85.468491,"marketCap":41415614115.37},{"date":"2024-06-21","current":43.866156,"twenty":15.841528,"median":31.485125,"eighty":85.581978,"marketCap":39824219396.61},{"date":"2024-06-28","current":45.436656,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":40737102327.33},{"date":"2024-07-05","current":46.209907,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":41309547172.12},{"date":"2024-07-12","current":47.281654,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":42963991363.06},{"date":"2024-07-15","current":47.281654,"twenty":15.818034,"median":31.394177,"eighty":85.990668,"marketCap":43152064633.5},{"date":"2024-08-02","current":44.272889,"twenty":15.741453,"median":31.201154,"eighty":86.195362,"marketCap":44210960292.65},{"date":"2024-08-09","current":43.014896,"twenty":15.741453,"median":31.201154,"eighty":84.363274,"marketCap":43794562967.78},{"date":"2024-08-16","current":45.710595,"twenty":15.741453,"median":31.201154,"eighty":83.962818,"marketCap":46020941359.68},{"date":"2024-08-23","current":46.418876,"twenty":15.741453,"median":31.201154,"eighty":83.592523,"marketCap":47626372624.72},{"date":"2024-08-30","current":45.805737,"twenty":15.741453,"median":31.201154,"eighty":83.199613,"marketCap":47269997055.1},{"date":"2024-09-06","current":45.150312,"twenty":15.741453,"median":31.201154,"eighty":82.795478,"marketCap":47112822724.29},{"date":"2024-09-13","current":43.733749,"twenty":15.741453,"median":31.201154,"eighty":82.469924,"marketCap":46054603558.91},{"date":"2024-09-20","current":45.192598,"twenty":15.741453,"median":31.201154,"eighty":82.039594,"marketCap":47462516587.04},{"date":"2024-09-27","current":44.008604,"twenty":15.741453,"median":31.201154,"eighty":81.796364,"marketCap":45577615083.94},{"date":"2024-10-04","current":44.8226,"twenty":15.741453,"median":31.201154,"eighty":81.650426,"marketCap":45789892958.1},{"date":"2024-10-11","current":45.034027,"twenty":15.741453,"median":31.201154,"eighty":81.051706,"marketCap":45471085814.96},{"date":"2024-10-18","current":45.203169,"twenty":15.741453,"median":31.201154,"eighty":80.673764,"marketCap":45181771588.11},{"date":"2024-10-25","current":43.395465,"twenty":15.741453,"median":31.201154,"eighty":79.929106,"marketCap":42824171488.68},{"date":"2024-10-31","current":45.076313,"twenty":15.741453,"median":31.201154,"eighty":79.086292,"marketCap":44338714216.59},{"date":"2024-11-08","current":23.061963,"twenty":15.732274,"median":30.643838,"eighty":78.376176,"marketCap":43661674072.7},{"date":"2024-11-15","current":23.302476,"twenty":15.732274,"median":30.454139,"eighty":52.554614,"marketCap":43374550679.55},{"date":"2024-11-22","current":22.482544,"twenty":15.732274,"median":30.401826,"eighty":52.071623,"marketCap":42186009596.39},{"date":"2024-11-29","current":22.318557,"twenty":15.732274,"median":30.334902,"eighty":51.88887,"marketCap":42718018145.77},{"date":"2024-12-06","current":22.537206,"twenty":15.732274,"median":30.202359,"eighty":51.680009,"marketCap":43528672494.7},{"date":"2024-12-13","current":22.602801,"twenty":15.732274,"median":30.13984,"eighty":51.23618,"marketCap":43060561658.31},{"date":"2024-12-20","current":22.438814,"twenty":15.732274,"median":30.092447,"eighty":51.014265,"marketCap":41267393050.42},{"date":"2024-12-27","current":22.89251,"twenty":15.732274,"median":30.057852,"eighty":50.68792,"marketCap":42014127583.17},{"date":"2025-01-03","current":22.854246,"twenty":15.732274,"median":30.013965,"eighty":50.217983,"marketCap":42075712866},{"date":"2025-01-10","current":22.526274,"twenty":15.7304,"median":29.981195,"eighty":49.163236,"marketCap":41357424220.33},{"date":"2025-01-17","current":22.072578,"twenty":15.7304,"median":29.8898,"eighty":48.45572,"marketCap":41218860202.53},{"date":"2025-01-24","current":22.056179,"twenty":15.7304,"median":29.842804,"eighty":47.722096,"marketCap":41006037214.49},{"date":"2025-01-31","current":32.066996,"twenty":15.7304,"median":29.792729,"eighty":47.270589,"marketCap":43228239899.45},{"date":"2025-02-07","current":31.518451,"twenty":15.7304,"median":29.792729,"eighty":46.516772,"marketCap":43185471262.61},{"date":"2025-02-14","current":31.625402,"twenty":15.7304,"median":29.792729,"eighty":46.191026,"marketCap":43025162552.6},{"date":"2025-02-21","current":32.135858,"twenty":15.7304,"median":29.792729,"eighty":46.13785,"marketCap":44672438730.76},{"date":"2025-02-28","current":33.019632,"twenty":15.7304,"median":29.792729,"eighty":45.930637,"marketCap":45808555597.44},{"date":"2025-03-07","current":33.965435,"twenty":15.728527,"median":29.788798,"eighty":45.798539,"marketCap":47684395829.03},{"date":"2025-03-14","current":33.616527,"twenty":15.728527,"median":29.788798,"eighty":45.697226,"marketCap":47372923461.69},{"date":"2025-03-21","current":33.462021,"twenty":15.728527,"median":29.788798,"eighty":45.536889,"marketCap":46793573769.54},{"date":"2025-03-28","current":32.837181,"twenty":15.728527,"median":29.788798,"eighty":45.417077,"marketCap":45256999058.78},{"date":"2025-04-04","current":32.910692,"twenty":15.728527,"median":29.788798,"eighty":45.358128,"marketCap":46930689894.65},{"date":"2025-04-11","current":28.911716,"twenty":15.7304,"median":29.784868,"eighty":45.194712,"marketCap":41677459532.98},{"date":"2025-04-17","current":30.639215,"twenty":15.7304,"median":29.784868,"eighty":45.124941,"marketCap":44845997107.55},{"date":"2025-04-25","current":31.299454,"twenty":15.728527,"median":29.784868,"eighty":45.06475,"marketCap":45645722852.58},{"date":"2025-05-02","current":32.102637,"twenty":15.728527,"median":29.784868,"eighty":45.020529,"marketCap":45944348076.13}],"updateTime":1746425904355}}}